Medical Tubing Market Size
The Global Medical Tubing Market reached US$ 11.25 billion in 2024 and is expected to reach US$ 22.47 billion by 2033, growing at a CAGR of 8.3% during the forecast period 2025-2033.
Medical tubing is a flexible, hollow conduit intended for transporting fluids, gasses, or other substances within the body or between medical devices and patients. Its design is critical for providing the safe and effective administration of medicines, nutrients, and other therapeutic substances. Medical tubing is constructed from a variety of biocompatible materials, including silicone, PVC (polyvinyl chloride), polyurethane, and thermoplastics. These materials are chosen for their flexibility, durability, and chemical resistance. This adaptability enables medical tubing to be employed in a variety of applications, including intravenous (IV) therapy, respiratory support, and surgical procedures.
The increasing demand for minimally invasive procedures is the driving factor that drives the market over the forecast period. Due to increasing demand for minimally invasive procedures, the manufacture and launch of devices like catheters are upsurging and the advancements in technology are also being implemented in the recently launched products. For instance, in May 2024, Penumbra launched the MIDWAY 43 and MIDWAY 62 delivery catheters, which are intended to provide optimal tracking and a stable platform for the delivery of various embolization therapies in the neurovasculature. Based on Penumbra's RED catheter technology, these MIDWAY intermediate catheters are a substantial improvement in the intermediate access device industry.
Executive Summary
For more details on this report – Request for Sample
Market Dynamics: Drivers & Restraints
Increasing demand for minimally invasive procedures
Minimally invasive procedures, which include smaller incisions and less harm to the body, are gradually replacing traditional open surgeries due to their various benefits. These procedures often lead to speedier recovery times, lower risk of complications, less postoperative pain, and shorter hospital stays. As a result, both patients and healthcare practitioners are increasingly adopting these procedures, creating a rise in demand for specialized medical tubing required for their implementation.
Medical tubing is essential in a wide range of minimally invasive treatments in medical specialties such as cardiology, gastrointestinal, urology, and neurosurgery. For instance, catheters and guidewires are critical components in angioplasty and endoscopic treatments. These tubes must be precisely engineered to allow for the successful delivery of medicinal substances or equipment while maintaining patient safety. The number of endoscopy procedures is increasing day by day. This increase in number upsurges the demand for medical tubing. For instance, according a to global survey in 2024, around 32 percent of surgeons reported they performed over 100 endoscopy procedures a year. A further 13.6 percent of surveyed surgeons perform between 50 and 99 endoscopies in a year.
The products of medical tubing in various medical specialties using advanced technologies have been launched in recent times. For instance, in January 2023, Omnivision, a semiconductor solutions manufacturer, introduced the new OVMed OCHTA, an ultra-thin medical-grade cable module for single-use endoscopes. The new module is designed for endoscopes used in minimally invasive surgery, such as spinal, ob/gyn, utero-renal, neuro, ophthalmic, and cardiac operations. The OVMed OCHTA cable modules have a six-wire cable, enabling manufacturers to add their own LED illumination.
High production costs
Factors such as high production costs are expected to hamper the global medical tubing market. Medical tube manufacture comprises a number of sophisticated components and processes, each of which adds to the overall expenditure. High-quality raw materials, restricted regulatory compliance, and innovative manufacturing procedures all contribute to higher production costs. For instance, medical-grade silicone might raise production costs by 20-30% when compared to conventional polymers. Extrusion machinery ranges between $100,000 and $500,000, depending on its complexity and output capacity. The extrusion machinery is vital for ensuring uniformity throughout the tube. All these material costs, extrusion machine costs, and regulatory compliance approval costs sum up to a hefty amount which makes the production high and hampers the market.
Market Segment Analysis
The global medical tubing market is segmented based on device type, application, structure, end-user, and region.
Catheters segment is expected to dominate the global medical tubing market share
The catheters segment dominates the global medical tubing market owing to the upsurge of minimally invasive procedures, and the increasing number of applications of catheters. Catheters are especially important in domains like cardiology, urology, and gastroenterology, where catheterization is required for diagnostic and therapeutic purposes. One of the primary causes of this growth is the increased frequency of chronic diseases, which demand frequent medical interventions. Catheterization is frequently used to treat and manage conditions such as cardiovascular disease, diabetes, and urinary tract infections. For instance, catheters are increasingly used in treatments such as angioplasty and stent implantation, allowing healthcare personnel to reach blood arteries with minimal harm to adjacent tissues.
For instance, according to the National Institute of Health, heart catheterization is among the most commonly performed heart procedures. In the United States, more than 1,000,000 cardiac catheterization procedures are conducted each year. Moreover, according to the International Society for Infectious Diseases, over 100 million urinary catheters are used globally each year, which equates to approximately 200 catheters being used every minute.
Advances in catheter technology have also contributed significantly to this segment's dominance. Innovations such as biocompatible materials and specific coatings have enhanced catheter performance and safety. There are product recent launches that use revolutionary technologies for manufacturing catheters. For instance, in February 2024, CERENOVUS, Inc., a division of Johnson & Johnson MedTech, announced the launch of the CEREGLIDE 71 Intermediate Catheter, a next-generation intermediate catheter with TruCourse intended for the revascularization of patients suffering from acute ischemic stroke. So, the increasing number of minimally invasive procedures, the increasing number of catheter applications across various medical domains, technological advancements, and the latest product launches make this segment the most dominating segment.
Market Geographical Share
North America is expected to hold a significant position in the global medical tubing market share
This dominance of North America in the global medical tubing market is largely due to the huge demand for medical devices containing tubing, such as catheters, IV lines, and surgical instruments, which are required for a variety of diagnostic and therapeutic treatments, adoption of minimally invasive procedures, technological advancements and presence of top players in the region. The increasing number of catheters used and the upsurge of minimally invasive procedures are observed in this geographic region. For instance, according to the American Heart Association, Inc., Every year, more than 1 million cardiac catheterization procedures are conducted in the United States, with the primary objective of diagnosing and treating patients with suspected or confirmed coronary heart disease and related diseases.
Moreover, according to the International Society for Infectious Diseases, In the United States, an estimated 30 million indwelling urethral catheters are traded each year, with around 20% of hospitalized patients using one at any given time. The recent product launches and technological advancements are observed in this region resulting in the most dominating segment. For instance, in March 2024, Abbott launched the next iteration of its Navitor heart valve technology in the United States. Navitor Vision includes extremely visible markings. These markers aid in identifying depths ranging from 3MM to 4.5MM, hence increasing implant confidence and patient outcomes. The organization received FDA approval for its Navitor system in January 2023. It developed Navitor as the only self-expanding TAVI device that incorporates leaflets within the native valve. This design improves access to coronary arteries, allowing for future treatments to treat coronary artery disease.
The growing number of minimally invasive procedures, catheter applications in a wide range of medical disciplines, technical advances, and the introduction of novel products make North America the most dominating geographical region.
Asia Pacific is growing at the fastest pace in the global medical tubing market
The Asia Pacific region is emerging as the fastest-growing market for global medical tubing. One of the most significant drivers of growth in the Asia Pacific medical tubing market is the rising prevalence of chronic diseases that demand frequent medical treatments. The region is experiencing an increase in health problems like diabetes, cardiovascular disease, and respiratory ailments. As a result, there is an increasing demand for effective treatment alternatives that frequently require specialized medical tubing for operations such as intravenous treatments and minimally invasive surgery.
In recent times, there have been launches of products that use novel technology and help in enhancing treatment efficiency. For instance, Philips, a global pioneer in health technology, announced at India Live 2024 in New Delhi that it has established over 1500 Cath Lab (interventional suite) installations across the Indian subcontinent. Philips also announced the launch of two novel approaches designed to reduce the prevalence of cardiovascular disease (CVD) in India. OmniWire, the world's first solid core pressure wire for coronary artery interventional operations, was launched in India.
Competitive Landscape
The major global players in the global medical tubing market include Saint-Gobain, Freudenberg Medical, W. L. Gore & Associates, Inc., The Lubrizol Corporation, TE Connectivity, Nordson Corporation, Elkem, RAUMEDIC AG, Teknor Apex, Zeus Company LLC among others.
Emerging Players
Vanguard Products Corporation, Bentec Medical, and MicroLumen among others
Key Developments
- In October 2024, Boston Scientific Corporation announced that the navigation-enabled FARAWAVE NAV Ablation Catheter for the treatment of paroxysmal atrial fibrillation (AF) has received FDA approval, as well as FDA 510(k) clearance for the new FARAVIEW Software, which will be used in conjunction with the FARAPULSE Pulsed Field Ablation (PFA) System to provide visualization for cardiac ablation procedures. These technologies are only compatible with Boston Scientific's existing cardiac mapping technology and the company's latest product, the OPAL HDx Mapping System.
- In December 2024, NuGen Medical Devices announced the launch of its InsuJet needle-free insulin delivery system in Canada. It received an initial order of 2,500, followed by a second order of 750 InsuJet starting kits plus consumables. This represents revenue of $670,000.
- In October 2024, Husky Technologies and Kriya Medical Technologies Pvt. Ltd. successfully implemented India's first ICHOR-integrated medical system, marking a significant milestone. Kriya's Chennai factory will begin manufacturing 13×100 and 13x75mm blood collection tubes as part of a new agreement.
| Metrics | Details | |
| CAGR | 8.3% | |
| Market Size Available for Years | 2018-2033 | |
| Estimation Forecast Period | 2025-2033 | |
| Revenue Units | Value (US$ Mn) | |
| Segments Covered | Device Type | Silicone, Polyolefins, Polyvinyl Chloride, Polycarbonates, Fluoropolymers, Others |
| Application | Catheters, Bulk Disposable Tubing, Drug Delivery Systems, Biopharmaceutical Laboratory Equipment, Others | |
| Structure | Single-lumen, Co-extruded, Multi-lumen, Tapered or bump tubing, Braided tubing | |
| End-User | Hospitals, Ambulatory Surgical Centers, Others | |
| Regions Covered | North America, Europe, Asia-Pacific, South America, and Middle East & Africa | |
Why Purchase the Report?
- Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
- Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
- Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
- Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
- Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
- Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
- Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
- Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
- Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
- Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
- Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
- Post-market Surveillance: Uses post-market data to enhance product safety and access.
- Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.
The global medical tubing market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.
Target Audience 2025
- Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
- Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
- Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
- Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
- Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
- Supply Chain: Distribution and Supply Chain Managers.
- Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
- Academic & Research: Academic Institutions.
